Neuroactive Steroids. 2.3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)A Receptor

被引:96
作者
Botella, Gabriel Martinez [1 ,4 ]
Salituro, Francesco G. [1 ]
Harrison, Boyd L. [1 ]
Beresis, Richard T. [2 ]
Bai, Zhu [3 ]
Blanco, Maria-Jesus [1 ]
Belfort, Gabriel M. [1 ,5 ]
Dai, Jing [1 ]
Loya, Carlos M. [1 ,6 ]
Ackley, Michael A. [1 ]
Althaus, Alison L. [1 ]
Grossman, Scott J. [1 ]
Hoffmann, Ethan [1 ]
Doherty, James J. [1 ]
Robichaud, Albert J. [1 ]
机构
[1] Sage Therapeut Inc, 215 First St, Cambridge, MA 02142 USA
[2] Shanghai Chempartner, 998 Halei Rd, Shanghai 201203, Peoples R China
[3] WuXi AppTec, 288 Fute Zhong Rd, Shanghai 200131, Peoples R China
[4] Praxis Precis Med, Cambridge, MA USA
[5] Takeda Pharmaceut Inc, Osaka, Japan
[6] Collegium Pharmaceut Inc, Canton, MA USA
关键词
GABA(A) RECEPTORS; ANTIEPILEPTIC DRUGS; EILAT CONFERENCE; PROGRESS REPORT; NEUROSTEROIDS; BINDING; SUBUNIT;
D O I
10.1021/acs.jmedchem.7b00846
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Certain classes of neuroactive steroids (NASs) are positive allosteric modulators (PAM) of synaptic and extrasynaptic GABA(A) receptors. Herein, we report new SAR insights in a series of 5 beta-nor-19-pregnan-20-one analogues bearing substituted pyrazoles and triazoles at C-21, culminating in the discovery of 3 alpha-hydroxy-3 beta-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5 beta-pregnan-20-one (SAGE -217, 3), a potent GABA(A) receptor modulator at both synaptic and extrasynaptic receptor subtypes, with excellent oral DMPK properties. Compound 3 has completed a phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) clinical trial and is currently being studied in parallel phase 2 clinical trials for the treatment of postpartum depression (PPD), major depressive disorder (MDD), and essential tremor (ET).
引用
收藏
页码:7810 / 7819
页数:10
相关论文
共 30 条
[1]   Neurosteroids promote phosphorylation and membrane insertion of extrasynaptic GABAA receptors [J].
Abramian, Armen M. ;
Comenencia-Ortiz, Eydith ;
Modgil, Amit ;
Vien, Thuy N. ;
Nakamura, Yasuko ;
Moore, Yvonne E. ;
Maguire, Jamie L. ;
Terunuma, Miho ;
Davies, Paul A. ;
Moss, Stephen J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (19) :7132-7137
[2]  
Althaus A. L., UNPUB
[3]   Two tyrosine residues on the alpha subunit are crucial for benzodiazepine binding and allosteric modulation of gamma-aminobutyric acid(A) receptors [J].
Amin, J ;
BrooksKayal, A ;
Weiss, DS .
MOLECULAR PHARMACOLOGY, 1997, 51 (05) :833-841
[4]  
[Anonymous], 2015, STUD SAGE 547 SUP RE
[5]   Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function [J].
Belelli, Delia ;
Harrison, Neil L. ;
Maguire, Jamie ;
Macdonald, Robert L. ;
Walker, Matthew C. ;
Cope, David W. .
JOURNAL OF NEUROSCIENCE, 2009, 29 (41) :12757-12763
[6]  
Bialer M, 2017, EPILEPSIA, V58, P181, DOI [10.1111/epi.14557, 10.1111/epi.13634]
[7]   Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII) [J].
Bialer, Meir ;
Johannessen, Svein I. ;
Levy, Rene H. ;
Perucca, Emilio ;
Tomson, Torbjorn ;
White, H. Steve .
EPILEPSY RESEARCH, 2015, 111 :85-141
[8]   Neuroactive Steroids. 1. Positive Allosteric Modulators of the (γ-Aminobutyric Acid)A Receptor: Structure-Activity Relationships of Heterocyclic Substitution at C-21 [J].
Botella, Gabriel Martinez ;
Salituro, Francesco G. ;
Harrison, Boyd L. ;
Beresis, Richard T. ;
Bai, Zhu ;
Shen, Kaisheng ;
Belfort, Gabriel M. ;
Loya, Carlos M. ;
Ackley, Michael A. ;
Grossman, Scott J. ;
Hoffmann, Ethan ;
Jia, Shiling ;
Wang, Jiamiao ;
Doherty, James J. ;
Robichaud, Albert J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (08) :3500-3511
[9]   GABAergic dysfunction in mood disorders [J].
Brambilla, P ;
Perez, J ;
Barale, F ;
Schettini, G ;
Soares, JC .
MOLECULAR PSYCHIATRY, 2003, 8 (08) :721-737
[10]  
Ellenbogen A, 2016, NEUROLOGY, V86